[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612050":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":46,"responsibleParty":63,"collaborators":26,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":69,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":26,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":48,"whyStopped":26,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Gaziosmanpasa Research and Education Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Magnesium Sulfate 2 Ampoules","EXPERIMENTAL","Participants receive 2 ampoules (8 ml total) of intravenous magnesium sulfate diluted in 100 ml normal saline, administered over 15 minutes.",[13],"Drug: Magnesium Sulfate (2 Ampoules)",{"label":15,"type":16,"description":17,"interventionNames":18},"Intravenous Dexketoprofen","ACTIVE_COMPARATOR","Participants receive 50 mg of intravenous dexketoprofen diluted in 100 ml normal saline, administered over 15 minutes.",[19],"Drug: Dexketoprofen",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Magnesium Sulfate (2 Ampoules)","Intravenous administration of 2 ampoules (8 ml total) of magnesium sulfate diluted in 100 ml normal saline, infused over 15 minutes.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Dexketoprofen","Intravenous administration of 50 mg dexketoprofen diluted in 100 ml normal saline, infused over 15 minutes.",[15],[32],{"name":33,"affiliation":34,"role":35},"havva betül bacak, md","SBÜ Gaziosmanpaşa Training and Research Hospital","PRINCIPAL_INVESTIGATOR",[37,42],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},"ecenur çelikoğlu, md","CONTACT","+90 538 54 92 848","ecenurcelikoglu14@gmail.com",{"name":43,"role":39,"phone":44,"phoneExt":26,"email":45},"yağmur acıyiyen, md","+905425669593","yagmuraciyiyen95@gmail.com",[47],{"facility":34,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":26,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"RECRUITING","Gaziosmanpaşa","Outside of the US","33400","Turkey (Türkiye)",{"type":54,"coordinates":55},"Point",[56,57],32.86652,39.89619,{"lat":57,"lon":56},[60,62],{"name":43,"role":39,"phone":61,"phoneExt":26,"email":45},"+9005425669593",{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},{"type":64,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"SPONSOR_INVESTIGATOR","Havva Betül Bacak","md","100612050","iv-magnesium-in-the-treatment-of-acute-dysmenorrhea-100612050",false,"NCT07248540","IV Magnesium in the Treatment of Acute Dysmenorrhea","Evaluation of Intravenous Magnesium Administration in the Treatment of Dysmenorrhea","IVMAG","Inclusion Criteria:\n\nFemale patients aged 18 to 35 years\n\nPresenting to the obstetrics and gynecology emergency department with a diagnosis of primary dysmenorrhea\n\nHaving regular menstrual cycles within the last 6 months\n\nHaving a Visual Analog Scale (VAS) pain score of ≥6 at emergency admission\n\nProviding written informed consent for participation in the study\n\nExclusion Criteria:\n\nPatients with secondary dysmenorrhea or underlying gynecological pathology\n\nPregnancy or breastfeeding\n\nUse of analgesics or muscle relaxants within the last 3 days\n\nKnown allergy to magnesium sulfate or dexketoprofen trometamol\n\nHistory of renal failure, cardiac arrhythmia, or serious systemic disease\n\nInability to assess pain due to mental disability or communication disorder\n\nFailure to provide informed consent for participation in the study","FEMALE","18 Years","35 Years",{"count":79,"type":80},60,"ESTIMATED","INTERVENTIONAL",[83],"NA","This prospective, randomized, double-blind clinical trial aims to evaluate the analgesic efficacy of intravenous magnesium sulfate in women presenting to the emergency department with acute dysmenorrhea. Participants will be randomized into two groups receiving either 2 ampoules of magnesium sulfate or intravenous dexketoprofen. Pain levels will be assessed using the Visual Analog Scale (VAS) before and after treatment.",[86],"Dysmenorrhea",[86,88,89],"Magnesium Therapy","Pain Management","2025-11-18",{"date":92,"type":93},"2025-11-25","ACTUAL",{"date":95,"type":93},"2025-07-01",{"date":97,"type":80},"2026-01-01",{"name":65,"class":6},1]